Efficacy and Safety of SHR-1905 Injection in Subjects With Chronic Rhinosinusitis With Nasal Polyps
Clinical trial NCT07132827 · RECRUITING
Trial details
- NCT number
- NCT07132827
- Sponsor
- Guangdong Hengrui Pharmaceutical Co., Ltd
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2025-08-28
- Primary completion
- 2028-04-01
- Enrollment
- 280
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.